Department of Ophthalmology, Beijing Children Hospital, Capital Medical University, National Center for Children's Health, China, Beijing, China.
Department of Ophthalmology, The First Medical Center of Chinese PLA General Hospital, Beijing, China.
Acta Ophthalmol. 2020 Dec;98(8):808-815. doi: 10.1111/aos.14325. Epub 2020 Jul 12.
The ocular choroid is a sensitive biomarker of vascular perfusion in optic neuritis (ON) patients due to its vascular structures. The purpose of this study was to evaluate alterations in sub-macular choroidal thicknesses (sub-MCT) in aquaporin-4 immunoglobulin G antibodies (AQP4-IgG) sero-positive neuromyelitis optica spectrum disease (AQP4-IgG+/NMOSD) and isolated ON (ION) patients using optical coherence tomography (OCT).
A total of 208 ON patients (275 eyes) and healthy controls (HCs) who underwent sub-MCT and retinal microstructure detection with OCT were enrolled in this study.
Among all the ON patients, 102 (49.0%) cases were identified as serum AQP4-IgG-positive, with 106 (51.0%) cases being negative, excluding multiple sclerosis as the ION cohort. The sub-MCT in the AQP4-IgG+/NMOSD patients decreased in 0-6 months after ON attacks. However, for the ION cohort, the sub-MCT decreased in 0-2 months and then stayed normal or slightly increased in 2-4 months after the first ON attack, finally sharply decreasing after 6 months. For unilateral AQP4-IgG+/NMOSD patients, eyes without ON also presented retinal layer thinning and sub-MCT slight reduction independent of ON attacks.
The sub-MCT in AQP4-IgG+/NMOSD patients were reduced at all stages of ON, which distinguished the ION patients as decreasing only at chronic stage of ON. It implied that ocular vascular hypoperfusion plays a potential role in ON pathogenesis and the different patterns could be caused by the distinct pathogenesis of AQP4-IgG+/NMOSD and ION.
由于眼部脉络膜的血管结构,它是视神经炎(ON)患者血管灌注的敏感生物标志物。本研究旨在使用光学相干断层扫描(OCT)评估水通道蛋白-4 免疫球蛋白 G 抗体(AQP4-IgG)阳性视神经脊髓炎谱系疾病(AQP4-IgG+/NMOSD)和孤立性 ON(ION)患者黄斑下脉络膜厚度(sub-MCT)的变化。
本研究共纳入 208 例接受 OCT 下 sub-MCT 和视网膜微观结构检测的 ON 患者(275 只眼)和健康对照者(HCs)。
在所有 ON 患者中,102 例(49.0%)血清 AQP4-IgG 阳性,106 例(51.0%)阴性,排除多发性硬化作为 ION 队列。AQP4-IgG+/NMOSD 患者的 sub-MCT 在 ON 发作后 0-6 个月内减少。然而,对于 ION 队列,sub-MCT 在 0-2 个月内减少,然后在首次 ON 发作后 2-4 个月内保持正常或略微增加,最后在 6 个月后急剧减少。对于单侧 AQP4-IgG+/NMOSD 患者,即使没有 ON 发作,眼睛也会出现视网膜层变薄和 sub-MCT 轻微减少。
AQP4-IgG+/NMOSD 患者的 sub-MCT 在 ON 的各个阶段均减少,这将 ION 患者与仅在 ON 慢性阶段减少区分开来。这表明眼部血管低灌注在 ON 发病机制中发挥了潜在作用,不同的模式可能是由于 AQP4-IgG+/NMOSD 和 ION 的不同发病机制引起的。